Catalyst Bio builds modular, closed-loop bioreactor systems that automate GMP-grade cell expansion workflows. Spun from RMIT bioengineering, the platform reduces manufacturing time by 40% and contamination risk significantly. The startup is partnering with Videregen and Nyal Health on clinical programs.